Key result
A 10 mmHg increase in nighttime systolic blood pressure in hospitalized patients was associated with a higher risk of death, ESRD, or a 50% decline in GFR (HR 1.12; 95% CI 1.03-1.23).
Why the study?
Does nighttime systolic blood pressure in hospitalized patients predict death, ESRD, or decline in GFR in hypertensive patients?
Cohort (n=1,085)
No
Does nighttime systolic blood pressure in hospitalized patients predict death, ESRD, or decline in GFR in hypertensive patients?
Hazard Ratio: 1.12 (95% CI 1.03–1.23)
Nighttime systolic blood pressure measured during hospitalization is an independent predictor of adverse clinical outcomes, including death and renal decline, in hypertensive patients.
Nighttime SBP monitoring may aid risk stratification in hospitalized hypertensives; extends ambulatory BP data but leaves causal effects open.
Nighttime systolic blood pressure (BP) from ambulatory blood pressure monitoring (ABPM) is more predictive than clinic BP for cardiovascular disease, stroke, and death even after controlling for clinic BP. However, ABPM is expensive and burdensome to obtain regularly. BPs obtained in the hospital may provide a window into nighttime BP. We conducted a retrospective cohort study of all hypertensive patients admitted to the Louis Stokes Cleveland Department of Veterans Affairs Medical Center (LSCDVAMC) in 2002 and 2003 with one or more BP recorded between midnight and 6 am on the day of or the day before discharge. The mean age of the study population (n = 1085) was 62 years and 96% were male. Twenty-two percent had coronary artery disease (CAD) and 34% had diabetes. The mean nighttime systolic BP was 132 mmHg and baseline glomerular filtration rate (GFR) was 83 mL/min per 1.73 m(2). Over a median follow-up period of 4.3 years, 266 subjects died, 22 developed end-stage renal disease (ESRD), 99 had a 50% decline in GFR, and 136 developed myocardial infarction (MI). The adjusted hazard ratios (HRs) associated with a 10 mmHg increase in nighttime systolic BP were 1.03 (95% confidence interval, 0.93-1.15) for death, 1.30 (0.94-1.80) for ESRD, 1.26 (1.08-1.47) for a 50% decline in GFR, 1.07 (0.92-1.23) for myocardial infarction, and 1.12 (1.03-1.23) for a composite of death, ESRD, or a 50% decline in GFR. In conclusion, nighttime systolic BP in hospitalized patients is an independent predictor of important clinical outcomes such as a composite of death, ESRD, or a 50% decline in GFR.
No takes yet. Share an insight, caveat, or question.
Drawz et al. (2010) conducted a cohort in Hypertension (n=1,085). 10 mmHg increase in nighttime systolic blood pressure was evaluated on Composite of death, ESRD, or a 50% decline in GFR (HR 1.12, 95% CI 1.03-1.23). A 10 mmHg increase in nighttime systolic blood pressure in hospitalized patients was associated with a higher risk of death, ESRD, or a 50% decline in GFR (HR 1.12; 95% CI 1.03-1.23).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: